MT team picture

AM-Pharma’s management team is highly experienced in drug development. The Company is also supported by an internationally-renowned Scientific Advisory Board as well as a Supervisory Board comprised of senior level executives associated with leading life science venture capital firms.

 

Erik van den Berg, MSc, MBA - Chief Executive Officer

Erik has over seventeen years experience in the pharmaceutical and biotechnology industries. He joined AM-Pharma in September 2007 as Chief Business Officer...

View Profile

Jacques Arend, MD - VP Clinical, Chief Medical Officer

Jacques has over twenty six years experience in the pharmaceutical industry, where he has held senior positions in medical and clinical development. He joined AM-Pharma in February 2008...

View Profile

Steve Connor, BSc - VP Preclinical Development

Steve has over thirty years management experience and extensive knowledge of the pharmaceutical and biological industries, including the management of R&D and manufacturing operations...

View Profile

Peter Verwayen - VP Finance

Peter has over 35 years experience in finance. He joined AM-Pharma in 2002. Most recently, he worked as Controller for Glaucus Proteomics, a Dutch biotech start-up company...

View Profile

Andrea van Elsas, PhD - VP Research

Andrea has managed various discovery alliances with biotech and academia in the field of Oncology. Previously, he was Proof-of-Concept Team Leader for Schering-Plough's Immune Oncology portfolio...

View Profile

Tim Knotnerus, MSc - Director Business Development 

Tim joined the AM-Pharma team in 2012, and has since been responsible for Business Development of the company. Previously, Tim was a senior associate at Aescap Venture which he joined in 2008.

View Profile